Professor of Radiology, Specializing in Nuclear Medicine
Dr Kostakoglu is a professor of Radiology and chief of Nuclear Medicine and Molecular Imaging in the department of Radiology at Icahn School of Medicine at Mount Sinai, New York, NY. Kostakoglu earned her medical degree from Ege University Faculty of Medicine in Izmir, Turkey. She completed her training as a resident in nuclear medicine followed by a fellowship in immunology and radioimmunotherapy at Memorial Sloan-Kettering Cancer Center, New York, NY.
Her work spans many areas of oncology and radioimmunotherapy, particularly, hematologic malignancies. Kostakoglu is the author of more than 80 peer-reviewed published articles, 16 published chapters and more than 240 published abstracts. As an active member of SNM, she served as the vice chair of the oncology track, as a member of the PET Center of Excellence Board of Directors. She has been the co-organizer/moderator for several CE activities. Lale is an active member of the Board of Regents of American College of Nuclear Physicians (ACNP), Procedure Guidelines Committee, House of Delegates, Academic Council and Correlative Imaging Council, served as the president of Academic Council (2010-2011) and currently is the president of the Northeastern Chapter of the SNM.
Dr Kostakoglu is also the chair of the Lymphoma Working Group for the American College of Radiology Imaging Network (ACRIN). She is also a member of the imaging subcommittee of the Cancer and Leukemia Group B (CALGB) (a.k.a ALLIANCE) and a liason to the lymphoma subcommittee of the same cancer research cooperative group, which are national clinical research groups sponsored by the National Cancer Institute. She brings her expertise in nuclear medicine to the editorial board of The Journal of Nuclear Medicine and European Journal of Nuclear Medicine .
She also brings her knowledge of nuclear medicine to the field of oncology by reviewing articles in more than 12 scientific journals including not only imaging journals but also oncology journals such as Journal of Clinical Oncology and Cancer. She serves on the scientific panel for the Department of Defense Congressionally Directed Medical Research Program and Radiologic Society of North America. Her active research includes multiple multicenter PET/CT studies in oncology, particularly in defining the role of PET/CT as a response marker.